Ricky is an academic scientist, analyst, strategy consultant, entrepreneur and now VC. He is the Founder and General Partner of Continuum Health Ventures, a Seed/A focused fund which invests in the democratization of the future of medicine, with a focus in digital healthtech and longevity startups. He is an active mentor and angel investor in several healthtech startups.
Prior to this, he founded and operated Q2 Metrics, a big-data predictive analytics company servicing healthcare companies; clients included Johnson & Johnson, Gilead, GE, Medtronic, McKesson, Stryker, Becton Dickinson, Boston Scientific, Abbott, and Biomet-Zimmer. In 2016, the organization was acquired by publicly traded F300 global conglomerate IQVIA.